IAM Iambic Therapeutics, Inc. - Common Stock
NASDAQIAM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
IAM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Company insiders 11 insiders · 5 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Thomas F. Miller | Chief Executive Officer | Oct. 14, 2026 A | 1,410,756 | 0 | 0 | $0 |
| Michael Secora | CFO & Chief Corp Dev Ofcr | Oct. 16, 2026 C | 279,902 | 0 | 0 | $0 |
| Frederick R Manby | Chief Technology Officer | Oct. 14, 2026 A | 1,862,665 | 0 | 0 | $0 |
| Peter A Olson | Chief Scientific Officer | Oct. 14, 2026 A | 30,909 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | Oct. 14, 2026 A | 71,459 | 0 | 0 | $0 |
| Jacob R Vogelstein | Director | Oct. 16, 2026 C | 742,546 | 0 | 0 | $0 |
| Evan Lockwood Rachlin | Director | Oct. 16, 2026 C | 57,754 | 1 | 0 | $11,500,000 |
| William H Rastetter | Director | Oct. 16, 2026 C | 200,920 | 0 | 0 | $0 |
| Shalini Sharp | Director | Oct. 14, 2026 A | · | 0 | 0 | $0 |
| Mary Tagliaferri | Director | Oct. 14, 2026 A | · | 0 | 0 | $0 |
| Kurt Von Emster | Director | Oct. 14, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 9 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| ECH · iShares, Inc. | 1.53% | 16,037,108 SH | Sept. 11, 2026 | Daily |
| EEMS · iShares, Inc. | 0.02% | 91,086 SH | Sept. 11, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 1,439,243 SH | Aug. 19, 2026 | Daily |
| IEMG · iShares, Inc. | 0.00% | 7,279,888 SH | Sept. 11, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 1,023,015 SH | Sept. 11, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 5,763,655 SH | Aug. 19, 2026 | Daily |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 5,305,184 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 446,446 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 92,974 SH | Aug. 19, 2026 | Daily |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.